Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Open, Randomized, Parallel, Multi-center Study in Children Aged 6 - 35 Months to Compare the Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V Administered According to a 0/4 Week Schedule

NCT01229397 is registered in ClinicalTrials.gov with Crucell Holland BV as lead sponsor.

NCT NCT01229397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01229397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Open, Randomized, Parallel, Multi-center Study in Children Aged 6 - 35 Months to Compare the Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V Administered According to a 0/4 Week Schedule
Lead sponsor
Crucell Holland BV
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2010
Completion date
November 30, 2010
Enrollment
205 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza